An online decision aid for patients with metastatic melanoma: results of the randomized controlled trial "PEF-Immun"
Background: Treatment decisions in metastatic melanoma (MM) are highly dependent on patient preferences and require the patients’ involvement. The complexity of treatment options with their individual advantages and disadvantages is often overwhelming. We therefore developed an online patient decisi...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
14 June 2024
|
| In: |
Deutsches Ärzteblatt
Year: 2024, Volume: 121, Issue: 12, Pages: 385-392 |
| ISSN: | 1866-0452 |
| DOI: | 10.3238/arztebl.m2024.0053 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.3238/arztebl.m2024.0053 Verlag, kostenfrei, Volltext: https://www.aerzteblatt.de/int/archive/article?id=239793 |
| Author Notes: | Pia Grabbe, Milena S. Borchers, Kathrin M. Gschwendtner, Sophia Strobel, Beate Wild, Marietta Kirchner, Katharina Kälber, Adriana Rendon, Julian Steininger, Friedegund Meier, Jessica C. Hassel, Christiane Bieber |
| Summary: | Background: Treatment decisions in metastatic melanoma (MM) are highly dependent on patient preferences and require the patients’ involvement. The complexity of treatment options with their individual advantages and disadvantages is often overwhelming. We therefore developed an online patient decision aid (PtDA) to facilitate shared decision making (SDM). |
|---|---|
| Item Description: | Gesehen am 21.07.2025 |
| Physical Description: | Online Resource |
| ISSN: | 1866-0452 |
| DOI: | 10.3238/arztebl.m2024.0053 |